| Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: a retrospective study JA Carrión, E Martínez-Bauer, G Crespo, S Ramírez, S Pérez-del-Pulgar, ... Journal of Hepatology 50 (4), 719-728, 2009 | 229 | 2009 |
| Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system YP Li, S Ramirez, SB Jensen, RH Purcell, JM Gottwein, J Bukh Proceedings of the National Academy of Sciences 109 (48), 19757-19762, 2012 | 149 | 2012 |
| Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system Y Zhou, KA Gammeltoft, LA Ryberg, LV Pham, HD Tjørnelund, A Binderup, ... Science Advances 8 (51), eadd7197, 2022 | 114 | 2022 |
| Efficacy of NS5A inhibitors against hepatitis C virus genotypes 1–7 and escape variants JM Gottwein, LV Pham, LS Mikkelsen, L Ghanem, S Ramirez, TKH Scheel, ... Gastroenterology 154 (5), 1435-1448, 2018 | 109 | 2018 |
| Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains YP Li, S Ramirez, JM Gottwein, TKH Scheel, L Mikkelsen, RH Purcell, ... Proceedings of the National Academy of Sciences 109 (18), E1101-E1110, 2012 | 105 | 2012 |
| In vitro efficacy of artemisinin-based treatments against SARS-CoV-2 Y Zhou, K Gilmore, S Ramirez, E Settels, KA Gammeltoft, LV Pham, ... Scientific Reports 11 (1), 14571, 2021 | 88 | 2021 |
| Robust HCV genotype 3a infectious cell culture system permits identification of escape variants with resistance to sofosbuvir S Ramirez, LS Mikkelsen, JM Gottwein, J Bukh Gastroenterology 151 (5), 973-985. e2, 2016 | 88 | 2016 |
| Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors S Ramirez, YP Li, SB Jensen, J Pedersen, JM Gottwein, J Bukh Hepatology 59 (2), 395-407, 2014 | 84 | 2014 |
| Differential sensitivity of 5′ UTR-NS5A recombinants of hepatitis C virus genotypes 1− 6 to protease and NS5A inhibitors YP Li, S Ramirez, D Humes, SB Jensen, JM Gottwein, J Bukh Gastroenterology 146 (3), 812-821. e4, 2014 | 72 | 2014 |
| Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication S Ramirez, C Fernandez-Antunez, A Galli, A Underwood, LV Pham, ... Antimicrobial Agents and Chemotherapy 65 (7), 10.1128/aac. 00097-21, 2021 | 70 | 2021 |
| Hepatitis C virus compartmentalization and infection recurrence after liver transplantation S Ramirez, S Perez-Del-Pulgar, JA Carrion, J Costa, P Gonzalez, ... American Journal of Transplantation 9 (7), 1591-1601, 2009 | 65 | 2009 |
| Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77 YP Li, S Ramirez, L Mikkelsen, J Bukh Journal of virology 89 (1), 811-823, 2015 | 62 | 2015 |
| Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor … J Prentoe, SBN Serre, S Ramirez, A Nicosia, JM Gottwein, J Bukh Journal of virology 88 (3), 1725-1739, 2014 | 57 | 2014 |
| Virology and pathogenesis of hepatitis C virus recurrence S Ramírez, S Pérez‐del‐Pulgar, X Forns Liver Transplantation 14 (S2), S27-S35, 2008 | 56 | 2008 |
| Evolutionary pathways to persistence of highly fit and resistant hepatitis C virus protease inhibitor escape variants SB Jensen, U Fahnøe, LV Pham, SBN Serre, Q Tang, L Ghanem, ... Hepatology 70 (3), 771-787, 2019 | 53 | 2019 |
| HCV genotype 6a escape from and resistance to velpatasvir, pibrentasvir, and sofosbuvir in robust infectious cell culture models LV Pham, S Ramirez, JM Gottwein, U Fahnøe, YP Li, J Pedersen, J Bukh Gastroenterology 154 (8), 2194-2208. e12, 2018 | 50 | 2018 |
| Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: essential tools in testing of antivirals and emerging … S Ramirez, J Bukh Antiviral research 158, 264-287, 2018 | 46 | 2018 |
| Substitutions at NS3 residue 155, 156, or 168 of hepatitis C virus genotypes 2 to 6 induce complex patterns of protease inhibitor resistance SB Jensen, SBN Serre, DG Humes, S Ramirez, YP Li, J Bukh, ... Antimicrobial Agents and Chemotherapy 59 (12), 7426-7436, 2015 | 44 | 2015 |
| HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape LV Pham, SB Jensen, U Fahnøe, MS Pedersen, Q Tang, L Ghanem, ... Journal of Hepatology 70 (3), 388-397, 2019 | 41 | 2019 |
| Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies J Pedersen, THR Carlsen, J Prentoe, S Ramirez, TB Jensen, X Forns, ... Hepatology 58 (5), 1587-1597, 2013 | 40 | 2013 |
